Parkinson’s News Forums › Forums › Parkinson’s Research › Results of First Patient-Tested AXO-Lenti Clinical Trial Anticipated

  • Parkinson’s Research

    Results of First Patient-Tested AXO-Lenti Clinical Trial Anticipated

    Posted by Forum Moderator on November 2, 2018 at 8:13 am

    The first patient has been dosed in Axovant’s Phase 1/2 clinical trial testing the investigational gene therapy AXO-Lenti-PD for the treatment of Parkinson’s disease. The patient reported no complications associated with surgery or administration of the therapy and was discharged as planned in the initial trial design.

    Preliminary data from the first group of treated patients are expected to be announced during the first half of 2019. Click here to read more about this story.

    What are your thoughts on this news?

    replied 5 years, 6 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .